Chargement en cours...
Capecitabine or infusional 5-fluorouracil for gastroesophageal cancer: a cost–consequence analysis
BACKGROUND: In patients with advanced gastroesophageal cancer, the phase iii Randomized ECF for Advanced and Locally Advanced Esophagogastric Cancer 2 (real-2) trial demonstrated equivalent clinical efficacy when capecitabine (x) was substituted for 5-fluorouracil (5fu) in the epirubicin–cisplatin–5...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Multimed Inc.
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3070713/ https://ncbi.nlm.nih.gov/pubmed/21505591 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|